GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS
Clinical trial NCT05266001 · COMPLETED
Trial details
- NCT number
- NCT05266001
- Sponsor
- Nationwide Children's Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2025-09-10
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.